Kiichi Sugimoto, MD (he/him/his)

Professor
Department of Coloproctological Surgery, Juntendo University Faculty of Medicine, Tokyo, Japan
Juntendo University Faculty of Medicine
Bunkyo-ku, Tokyo, Japan

Kiichi Sugimoto, M.D., Ph.D., Professor, Department of Coloproctological Surgery, Juntendo University Faculty of Medicine

2025/10　　　　　Professor in Surgery, Juntendo University Hospital, Department of Coloproctological Surgery, Tokyo
2024/08　　　　　Senior Associate Professor in Surgery, Juntendo University Hospital, Department of Coloproctological Surgery, Tokyo
2019/06　　　　　Associate Professor in Surgery, Juntendo University Hospital, Department of Coloproctological Surgery, Tokyo
2016/08　　　　　Medical Staff in Surgery, Juntendo University Hospital, Department of Coloproctological Surgery, Tokyo
2013/12-2016/07　Post-Doctral fellow in Johns Hopkins University, USA
2013/04-2013/11　Medical Staff in Surgery, Juntendo University Hospital, Department of Coloproctological Surgery, Tokyo
2011/04-2013/03　Medical Staff in Surgery, Juntendo University Shizuoka Hospital, Shizuoka
2007/05-2011/03　Medical Staff in Surgery, Juntendo University Hospital, Department of Coloproctological Surgery, Tokyo
2006/05-2007/04　Medical Staff in Surgery, Koshigaya City Hospital, Saitama
2005/05-2006/04　Medical Staff in Surgery, Juntendo University Urayasu Hospital, Chiba
2004/05-2005/04　Medical Staff in Surgery, Juntendo University Hospital, Department of Coloproctological Surgery, Juntendo University Hospital, Tokyo
2002/05-2004/04　Resident in Surgery, Juntendo University Hospital, Tokyo
2002/03　　　　　Passed the Examination of National Board

Presentation(s):

• EP794 - Pretreatment DNA methylation biomarkers predict pathological complete response to neoadjuvant therapy in locally advanced rectal cancer: toward personalized treatment strategies

  Monday, May 11, 2026
  10:36 AM - 10:41 AM ET

• EP795 - The Significance of Detecting Extramural Venous Invasion in Rectal Cancer

  Monday, May 11, 2026
  10:42 AM - 10:47 AM ET

• EPD516 - Circulating Tumor DNA Methylation Is A biomarker of Poor Recurrence-free Survival in Locally Advanced Rectal Cancer

  Monday, May 11, 2026
  5:03 PM - 5:08 PM ET